The global troponin diagnostic tests market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing incidence of cardiovascular diseases and rising awareness about the benefits of early diagnosis. The global troponin diagnostic tests market by type is segmented into CTnT, CTnI, and CTnC. The CTnT segment accounted for the largest share in 2018 due to its high specificity and sensitivity in diagnosing myocardial infarction (MI). The CTnI segment is expected to grow at a CAGR of 6% during the forecast period owing to its high specificity in diagnosing acute coronary syndrome (ACS) as well as MI. The CTnC segment accounted for a small share in 2018 due to its low sensitivity and specificity when compared with other types of troponins.
Some Of The Growth Factors Of This Market:
- The increasing number of people suffering from heart diseases is a major factor driving the growth of the troponin diagnostic tests market.
- The increasing awareness about the benefits of troponin diagnostic tests in diagnosing heart diseases is also driving the growth of this market.
- The growing geriatric population and their increased risk for developing heart diseases are also contributing to the growth of this market.
- Increasing prevalence rates for cardiovascular disease, which is one of the leading causes for death globally, are also fuelling this market's growth.
- Technological advancements in troponin diagnostic tests such as point-of-care testing and rapid test kits are expected to fuel this market's growth.
Industry Growth Insights published a new data on “Troponin Diagnostic Tests Market”. The research report is titled “Troponin Diagnostic Tests Market research by Types (CTnT, CTnI, CTnC), By Applications (Angina, Myocardial Infarction, Others), By Players/Companies Mindray Medical International Ltd, Nanosphere Inc, AXO Science SAS, Beckman Coulter Inc, British Heart Foundation, China Medical Technologies Inc (Inactive), Fujirebio Diagnostics Inc, John Hopkins University, QLIDA Diagnostics, Radiometer Medical ApS, Orangelife, Ortho-Clinical Diagnostics Inc”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Troponin Diagnostic Tests Market Research Report
By Type
CTnT, CTnI, CTnC
By Application
Angina, Myocardial Infarction, Others
By Companies
Mindray Medical International Ltd, Nanosphere Inc, AXO Science SAS, Beckman Coulter Inc, British Heart Foundation, China Medical Technologies Inc (Inactive), Fujirebio Diagnostics Inc, John Hopkins University, QLIDA Diagnostics, Radiometer Medical ApS, Orangelife, Ortho-Clinical Diagnostics Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Troponin Diagnostic Tests Market Report Segments:
The global Troponin Diagnostic Tests market is segmented on the basis of:
Types
CTnT, CTnI, CTnC
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Angina, Myocardial Infarction, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mindray Medical International Ltd
- Nanosphere Inc
- AXO Science SAS
- Beckman Coulter Inc
- British Heart Foundation
- China Medical Technologies Inc (Inactive)
- Fujirebio Diagnostics Inc
- John Hopkins University
- QLIDA Diagnostics
- Radiometer Medical ApS
- Orangelife
- Ortho-Clinical Diagnostics Inc
Highlights of The Troponin Diagnostic Tests Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CTnT
- CTnI
- CTnC
- By Application:
- Angina
- Myocardial Infarction
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Troponin Diagnostic Tests Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Troponin tests are used to diagnose a heart attack, stroke, or other medical condition. Troponin levels can be elevated in these situations and may indicate a problem.
Some of the major companies in the troponin diagnostic tests market are Mindray Medical International Ltd, Nanosphere Inc, AXO Science SAS, Beckman Coulter Inc, British Heart Foundation, China Medical Technologies Inc (Inactive), Fujirebio Diagnostics Inc, John Hopkins University, QLIDA Diagnostics, Radiometer Medical ApS, Orangelife, Ortho-Clinical Diagnostics Inc.
The troponin diagnostic tests market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Troponin Diagnostic Tests Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Troponin Diagnostic Tests Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Troponin Diagnostic Tests Market - Supply Chain
4.5. Global Troponin Diagnostic Tests Market Forecast
4.5.1. Troponin Diagnostic Tests Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Troponin Diagnostic Tests Market Size (000 Units) and Y-o-Y Growth
4.5.3. Troponin Diagnostic Tests Market Absolute $ Opportunity
5. Global Troponin Diagnostic Tests Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Troponin Diagnostic Tests Market Size and Volume Forecast by Type
5.3.1. CTnT
5.3.2. CTnI
5.3.3. CTnC
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Troponin Diagnostic Tests Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Troponin Diagnostic Tests Market Size and Volume Forecast by Application
6.3.1. Angina
6.3.2. Myocardial Infarction
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Troponin Diagnostic Tests Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Troponin Diagnostic Tests Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Troponin Diagnostic Tests Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Troponin Diagnostic Tests Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Troponin Diagnostic Tests Demand Share Forecast, 2019-2026
9. North America Troponin Diagnostic Tests Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Troponin Diagnostic Tests Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Troponin Diagnostic Tests Market Size and Volume Forecast by Application
9.4.1. Angina
9.4.2. Myocardial Infarction
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Troponin Diagnostic Tests Market Size and Volume Forecast by Type
9.7.1. CTnT
9.7.2. CTnI
9.7.3. CTnC
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Troponin Diagnostic Tests Demand Share Forecast, 2019-2026
10. Latin America Troponin Diagnostic Tests Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Troponin Diagnostic Tests Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Troponin Diagnostic Tests Market Size and Volume Forecast by Application
10.4.1. Angina
10.4.2. Myocardial Infarction
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Troponin Diagnostic Tests Market Size and Volume Forecast by Type
10.7.1. CTnT
10.7.2. CTnI
10.7.3. CTnC
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Troponin Diagnostic Tests Demand Share Forecast, 2019-2026
11. Europe Troponin Diagnostic Tests Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Troponin Diagnostic Tests Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Troponin Diagnostic Tests Market Size and Volume Forecast by Application
11.4.1. Angina
11.4.2. Myocardial Infarction
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Troponin Diagnostic Tests Market Size and Volume Forecast by Type
11.7.1. CTnT
11.7.2. CTnI
11.7.3. CTnC
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Poential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Troponin Diagnostic Tests Demand Share, 2019-2026
12. Asia Pacific Troponin Diagnostic Tests Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Troponin Diagnostic Tests Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Troponin Diagnostic Tests Market Size and Volume Forecast by Application
12.4.1. Angina
12.4.2. Myocardial Infarction
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Troponin Diagnostic Tests Market Size and Volume Forecast by Type
12.7.1. CTnT
12.7.2. CTnI
12.7.3. CTnC
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Troponin Diagnostic Tests Demand Share, 2019-2026
13. Middle East & Africa Troponin Diagnostic Tests Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Troponin Diagnostic Tests Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Troponin Diagnostic Tests Market Size and Volume Forecast by Application
13.4.1. Angina
13.4.2. Myocardial Infarction
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Troponin Diagnostic Tests Market Size and Volume Forecast by Type
13.7.1. CTnT
13.7.2. CTnI
13.7.3. CTnC
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Troponin Diagnostic Tests Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Troponin Diagnostic Tests Market: Market Share Analysis
14.2. Troponin Diagnostic Tests Distributors and Customers
14.3. Troponin Diagnostic Tests Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Mindray Medical International Ltd
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Nanosphere Inc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AXO Science SAS
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beckman Coulter Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. British Heart Foundation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. China Medical Technologies Inc (Inactive)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Fujirebio Diagnostics Inc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. John Hopkins University
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. QLIDA Diagnostics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Radiometer Medical ApS
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Orangelife
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Ortho-Clinical Diagnostics Inc
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook